A coagulant component has been purified from Cerastes cerastes venom, using gel filtration on a Sephadex G 100 (fine) column followed by chromatography on a Bio-Rex 70 column. This compound had a proteolytic effect and could coagulate human plasma deficient in factor VIII or (VIII + IX) with the formation of a firm clot. It could also clot plasma deficient in factor X, but the clot formed was soft and not complete. The compound had no effect on platelet aggregation and was nontoxic. This compound is believed to be primarily a factor X activator, as it could replace factor VIII in hemophilic plasmas.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0041-0101(86)90130-3DOI Listing

Publication Analysis

Top Keywords

coagulant component
8
cerastes cerastes
8
plasma deficient
8
deficient factor
8
factor viii
8
cerastes
4
component cerastes
4
cerastes egyptian
4
egyptian sand
4
sand viper
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!